Real-World study checks cholesterol Combo's safety and success
NCT ID NCT05559606
First seen Oct 31, 2025 · Last updated May 23, 2026 · Updated 31 times
Summary
This study watched 1,839 adults with high cholesterol who were given a new combination of two medicines (atorvastatin and ezetimibe) for 24 weeks. Researchers wanted to see how well the combo lowered bad cholesterol and if it was safe in everyday use. The goal was to understand how this treatment works outside of strict research settings.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRIMARY HYPERCHOLESTEROLEMIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Severance Hospital, Yonsei University Health System
Seoul, South Korea
Conditions
Explore the condition pages connected to this study.